Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review

MeSH terms

• Adult
• Age Factors
• Aged
• Aged, 80 and over
• Blood Glucose / metabolism
• Cerebral Hemorrhage / chemically induced
• Cerebral Hemorrhage / mortality
• Cerebral Infarction / diagnosis
• Cerebral Infarction / drug therapy*
• Cerebral Infarction / mortality
• Female
• Fibrinolytic Agents / adverse effects
• Fibrinolytic Agents / therapeutic use*
• France
• Humans
• Infusions, Intravenous
• Magnetic Resonance Imaging
• Male
• Middle Aged
• Neurologic Examination / drug effects
• Odds Ratio
• Prospective Studies
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Registries
• Risk Factors
• Survival Analysis
• Thrombolytic Therapy* / adverse effects
• Tissue Plasminogen Activator / adverse effects
• Tissue Plasminogen Activator / therapeutic use*
• Tomography, X-Ray Computed
• Treatment Outcome